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Has Global Fund support for civil society advocacy in the Former Soviet Union established 
meaningful engagement or ‘a lot of jabber about nothing’?   
 
Abstract 
Although civil society advocacy for health issues such as HIV transmission through injecting 
drug use is higher on the global health agenda than previously, its impact on national policy 
reform has been limited. In this paper we seek to understand why this is the case through an 
examination of civil society advocacy efforts to reform HIV/AIDS and drugs-related policies 
and their implementation in three former-Soviet Union countries. In-depth semi-structured 
interviews were conducted in Georgia, Kyrgyzstan and Ukraine by national researchers with 
representatives from a sample of 49 CSOs and 22 national key informants. We found that 
Global Fund support resulted in the professionalisation of CSOs, which increased confidence 
from government and increased CSO influence on policies relating to HIV/AIDS and illicit 
drugs. Interviewees also reported that the amount of funding for advocacy from the Global 
Fund was insufficient, indirect, and often interrupted.  CSOs were often in competition for 
Global Fund support, which caused resentment and limited collective action – further 
weakening capacity for effective advocacy.  
 
Introduction 
In May 2010, shortly before the XVIII International AIDS Conference in Vienna, the Global 
Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) and UNAIDS published a 
framework for Community Systems Strengthening (CSS), the principal aim of which was to 
strengthen ‘civil society engagement with the Global Fund’ (Global Fund 2010: iv-v). Civil 
society organisations (CSOs) perform various functions in a country’s health system: they 
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deliver services, monitor government behavior, and advocate on behalf of particular 
communities including marginalised groups (Rau, 2006; Cohn et al, 2011; Ibrahim & Hulme, 
2010). Studies suggest that CSO capacity – understood in terms of leadership, networking, 
credibility, and possession of information and resources – is essential for effective advocacy, 
while limited transparency and openness to CSO engagement among some governments are 
significant impediments (Nathan et al, 2002; Price 2003; Pollard and Court, 2005; and Court 
et al, 2006; Parker, 2009; Kendall and Lopez-Uribe 2010; Spicer et al 2011). Less is known 
about the effects of international funding on CSO advocacy in specific health or policy areas, 
such as HIV and injecting drug use (Caceres et al 2009; Edwards and Hulme 1998; Doyle 
and Patel 2008).   
 
The Global Fund has channeled substantial resources to CSOs to implement HIV/AIDS 
programmes: nearly 20% of the Global Fund’s Round 7 funding was channeled through 
CSOs (Cohn et al, 2011:3). Our study provides an in-depth, geographically focused study of 
the direct and indirect effects of Global Fund support for CSO advocacy for a specific health 
policy issue – an HIV/AIDS epidemic driven by intravenous drug use.  
 
In many countries of Eastern Europe and Central Asia, criminalisation of injecting drug use 
stimulates risky practices and can lead to human rights abuses and poor access to HIV/AIDS 
services, and hence represents a major structural driver of the HIV/AIDS epidemic (Wolfe & 
Malinowska-Sempruch, 2004; Rhodes et al, 2005; Latypov, 2009; Open Society Institute, 
2009; Sarang, et al 2010). We focus on three former Soviet Union (FSU) countries – Georgia, 
Kyrgyzstan and Ukraine – with low level/concentrated HIV/AIDS epidemics driven to a 
great extent by risky behaviors such as needle sharing between IDUs. Global Fund 
HIV/AIDS programmes have provided significant external resources for HIV/AIDS control 
Page 3 of 30
http://mc.manuscriptcentral.com/heapol
Manuscripts submitted to Health Policy and Planning
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 3
to these countries, which has enabled substantial scale-up in the delivery of HIV/AIDS 
services and population coverage (Chkhatarashvili et al, 2008; Murzalieva et al, 2009; 
Semigina, 2009). Key epidemic data and features of the Global Fund HIV/AIDS grants in 
the three countries are summarised in Table 1.  
 
 
 
Table 1: about here  
 
We adopt a health policy analysis approach to explore both national level advocacy by CSOs 
around national policy and laws, and local level advocacy focusing on sub-national 
government including law enforcement and its implementation of national policy in each of 
the three focus countries. Health policy analysis theory has made important progress in  
understanding how policy contexts and the strength of policy actors influence the 
prioritisation of certain health policies or health issues over others (Walt and Gilson 1994; 
Shiffman and Smith 2007). The aim of our paper is to identify the effects of Global Fund 
financing on CSO advocacy. One might hypothesise that Global Fund HIV/AIDS funding 
allocated specifically for advocacy would strengthen civil society actors’ capacity to 
advocate for changes in HIV/AIDS and drugs-related policies and their implementation, or 
lead to increased cooperation amongst CSOs as they take advantage, collectively, of a much-
needed additional source of financing. One might also reasonably anticipate indirect effects 
of Global Fund country programmes on CSO advocacy including: have the Global Fund’s 
Country Coordinating Mechanisms assisted advocacy by strengthening relations between 
government agencies and CSOs; have CSO Principal Recipients of Global Fund grants taken 
advantage of their privileged position to further advocacy?.  
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Methods 
 
The paper presents data from in-depth semi-structured interviews conducted in Georgia, 
Kyrgyzstan and Ukraine by national research teams (February - August 2010) with 
representatives from CSOs sampled on the basis of the following selection criteria: a) Global 
Fund HIV/AIDS programme grantees; b) working in the field of harm reduction for IDUs; c) 
operating in the capitals – Tbilisi, Bishkek and Kyiv; and d) agreeing to participate in the 
study. Based on these criteria our sample was: Georgia n=14, Kyrgyzstan n=16 and Ukraine 
n=19. While the sampled CSOs worked in the field of harm reduction for IDUs, some also 
provided related HIV/AIDS interventions targeting specific groups (Table 2). Interviewees 
were managers/directors, all were paid employees of these organisations, and some were also 
PLWHA and/or former IDUs or commercial sex workers (CSWs). In-depth semi-structured 
interviews were also conducted with purposively sampled national level stakeholders 
including representatives of government agencies and development agencies including 
donors and UN agencies (Georgia n=7, Kyrgyzstan n=9 and Ukraine n=6).  
 
Table 2: about here  
 
Semi-structured interviews were administered by national researchers using topic guides 
jointly designed with the authors. These were piloted in Tbilisi in January 2010 by 
researchers from Georgia, Kyrgyzstan, Ukraine and UK. Reflecting country contexts, minor 
adaptations were made to the topic guide. The fieldwork was conducted by professional 
researchers who were experienced in qualitative data collection and familiar with the 
sensitive topic area. They were employed by research organisations that were independent of 
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the organisations and individuals they interviewed. Interviewees gave informed consent 
before participating, and interviews were conducted in private spaces to ensure anonymity 
and confidentiality.  
 
CSO interviewees commented on the advocacy they had engaged in, the effects of Global 
Fund HIV/AIDS programmes on their advocacy activities, factors enabling or undermining 
advocacy and how relations with government and other CSOs had changed. National 
informants commented on these themes from their organisational perspective. Interviews 
followed a priori themes, but allowed respondents’ frames of experience and meaning to 
emerge, and were conducted until saturation of new themes was achieved. All interviews 
were recorded and transcribed, and translated professionally.  
 
The lead analyst undertook a systematic thematic analysis of the qualitative data adopting a 
framework approach described by Pope & Mays (2000) whereby a priori and emerging 
themes were drawn out and tabulated in a common analytic framework to enable cross-
country comparison. An investigator triangulation approach was adopted (see for example 
Seale, 2004): multiple researchers contributed to interpreting themes, which reinforced our 
confidence in the findings reported. When investigators’ interpretations differed, data were 
reexamined before agreeing on an interpretation; where this was not possible we do not 
report these themes. The analysis involved the following stages: 1) transcripts were 
systematically coded by the lead analyst and major themes drawn out; 2) themes were jointly 
agreed by country investigators and the lead analyst and interpretations revised if necessary; 
3) cross-country findings were summarised by tabulating them in the common analytic 
framework and agreed by the country investigators; 4) the paper was drafted and reviewed 
by country teams to confirm the accurate and coherent presentation of findings.   
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Ethical approval for the study was granted by the London School of Hygiene and Tropical 
Medicine (reference 5078) and by the Kyrgyz Medical Ethics Committee. The Georgian 
government requires ethical approval only for studies involving patients/biological samples. 
No ethical approval is required in Ukraine.   
 
Results  
 
We interviewed 14 of 16 Georgian CSOs receiving Global Fund HIV/AIDS grants, more 
than one third of all Kyrgyz Global Fund HIV/AIDS CSO grantees (n=16, 36%), but fewer 
in Ukraine (n=19, 14%). While it was difficult to interview large numbers of government 
officials due to problems of availability and a lack of willingness to participate, those we did 
interview were key informants in the field. We found considerable consistency between most 
interviewees’ accounts, including between CSO and government interviewees. In this section, 
we draw out the most important, commonly agreed themes across the different groups 
interviewed.  
 
Our study revealed a growing appetite among CSOs to advocate on HIV/AIDS and injecting 
drug use-related issues and policies, and there are several examples of active advocacy 
activities (Box 1). Where external support was provided, respondents cited two donors as 
primary sources: the Open Society Institute and the Global Fund. Global Fund HIV/AIDS 
grants have provided direct financial support for CSO advocacy as follows: Georgia, 
received $195,000 for advocacy activities through its Round 2 grant (14% of the total grant), 
plus $312,000 from single a funding stream a year later. Kyrgyzstan, received $716,580 from 
the first phase of its Round 7 grant (6.5% of the total grant) specifically for advocacy work, 
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while Ukraine received around $630,000 for advocacy from Rounds 1 (2% of the total grant) 
and 6 (0.1% of total) (Table 1). Activities supported through this direct advocacy funding are 
described below (see Box 2). We chose to focus our study on the Global Fund due to high 
levels of CSO financing to deliver HIV/AIDS services, direct financial support for CSO 
advocacy and the introduction of new models of working including Country Coordination 
Mechanisms. Additionally a body of data and analysis on Global Fund country HIV/AIDS 
programmes exist that are relatively accessible.  
 
 
Box 1: about here 
 
In spite of the Global Fund’s financial support, the vast majority of CSO, government and 
development partner interviewees agreed that CSO advocacy had had limited impact on both 
national policies and their implementation nationally and locally, which, in turn, constitute a 
major barrier to implementing Global Fund-supported HIV/AIDS programmes. Capturing 
this sentiment, a CSO interviewee said about the drug laws in Georgia: ‘When such 
legislation is in force the activities of the Global Fund are in vain’. In the following sections 
we ask whether Global Fund financed programmes have strengthened CSO advocacy efforts.   
 
To what extent has Global Fund financing supported civil society advocacy?  
Global Fund HIV/AIDS direct grant support for advocacy in the three focus countries 
primarily took the form of funding for conferences and meetings where CSO grantees 
contributed to the exchange of information and policy discourse with government agencies, 
as well as press conferences, communications and materials, advocacy training at ‘Summer 
Schools’ and multi-sectoral working groups established for the development of policy 
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proposals. While some interviewees welcomed this, others were critical of the quality of the 
training which consisted of one-off sessions rather than ongoing, systematic support, and 
tended to focus on a limited number of topics that reflected the priorities of the Global Fund 
country HIV/AIDS grant and its implementation rather than being grounded in vulnerable 
groups’ needs and wishes and/or locally determined priorities by smaller CSOs. ‘A lot of 
jabber about nothing’ as one Ukrainian interviewee described it. Examples of Global Fund 
financing directly allocated for advocacy activities are summarised in Box 2.  
 
Box 2 about here   
 
There was a relatively buoyant CSO advocacy environment in Ukraine, which interviewees 
described as stemming from the fact that two large CSOs – the International HIV/AIDS 
Alliance and the Network of People Living with HIV/AIDS – acted as the country’s Principal 
Recipients (PRs) for the Round Six HIV/AIDS grant. Their status as PRs raised the national 
profile of both CSOs in Ukraine and made them a powerful voice among the CSO 
community resulting in a number of successful national advocacy campaigns (Box 1). 
However, the relationship between the two Ukrainian CSO PRs and their CSO sub-grantees 
was widely described as ‘top-down’ and weakly aligned with sub-grantees’ priorities. Much 
advocacy work funded under the ‘supportive environment’ component of Ukraine’s Round 
Six HIV/AIDS grant took the form of issuing competitive tenders for mostly local level 
advocacy projects defined by the PRs for which CSO sub-grantees could bid. Some 
interviewees were positive about this, though were consistent in their criticism that the 
amount of funding available was insufficient to support local advocacy that was essential for 
the smooth running of CSO-run HIV/AIDS services, such as working to change attitudes of 
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local militia (police) commanders and officers on the street, or negotiating cooperation with 
local government and health officials.  
 
A common observation across the three countries was that most Global Fund support to 
improve CSO sub-grantees’ capacity was only indirectly associated with advocacy 
strengthening. Thus, Global Fund HIV/AIDS grants supported participation in international 
exchanges and conferences, and Global Fund-financed training strengthened the managerial 
and administrative capacity of numerous CSOs through increasing the professionalism, 
experience and qualifications of employees, as well as providing financial resources to hire 
new CSO employees including frontline service providers, managerial and administrative 
staff. This support strengthened CSOs to both deliver services more effectively, and as a 
beneficial side-effect, to conduct advocacy either at national or local level: ‘[it gave us] 
possibilities to show the community’s needs and start advocacy’ but ‘there is no targeted 
activity towards us’ (Kyrgyz CSO). In Georgia, the experience was similar, with 
interviewees noting that while Global Fund grants did not support CSOs to do advocacy 
directly ‘…advocacy activities are an indirect result of Global Fund funding’ (development 
partner, Georgia).  
 
Has dependency on Global Fund financing influenced civil society advocacy?  
Interviewees suggested that many CSOs were financially dependent on Global Fund grants. 
A Ukrainian government official described Global Fund grants as: ‘…a crutch, and without 
this crutch they won’t be able to walk. And I would like them to be taught how to walk by 
themselves’. Several CSO sub-grantees in Ukraine felt that financial dependence on short 
term Global Fund HIV/AIDS grants undermined their ability to criticise either PR for fear of 
losing further funding. This lack of space to input into decision making: ‘turned the civil 
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society sector into robots that are just implementing donors’ ideas’ (Ukrainian CSO). 
Economic dependence also had the effect of repositioning some CSOs as commercial entities, 
as the following CSO interviewee from Ukraine noted: ‘…the Global Fund has turned civil 
society into a public business - it means that there is an interest in subsequent and bigger 
grants’. 
 
CSO advocacy in Kyrgyzstan and Georgia – where government agencies acted as the PRs – 
was even more subdued at both at national and local levels. A key problem described by 
several CSOs in these countries was the perception that challenging government policies 
would prejudice their chances of receiving future Global Fund grants. Small CSOs receiving 
single Global Fund grants in Kyrgyzstan, and to some extent Georgia, felt particularly 
vulnerable, and were more cautious about embarking on advocacy activities, especially at the 
national level, than those larger, more visible, CSOs that received funding from multiple 
sources, although the subtle process of exclusion from future grants was not easy to prove. In 
Kyrgyzstan, an additional problem stemmed from breaks in Global Fund financing to CSOs, 
which created fragility and jeopardised both service delivery and staff retention. This 
undermined advocacy efforts since CSOs were forced to concentrate on maintaining a 
skeleton service with limited resources.  
 
Global Fund country HIV/AIDS programmes attached limited value to CSO advocacy – 
whether at national or local – because CSOs were widely regarded as service providers 
rather than advocates. A development partner in Georgia commented: ‘I cannot see that this 
[advocacy] is a key focus of the Global Fund. On the contrary, it has been absolutely 
abandoned’. In Kyrgyzstan, CSOs had a similar experience: ‘…little attention was paid to 
advocacy measures…the Global Fund strategy did not have emphasis, goals and objectives 
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of development of the nongovernmental sector (development partner, Kyrgyzstan). 
Furthermore, as a Kyrgyz CSO interviewee maintained, the Global Fund PRs actively sought 
to play down CSO advocacy: ‘…in general there is some feeling that the Global Fund tries 
to keep silence…’. In Georgia, the expectation of the PR was clear: that CSOs’ should not 
engage in advocacy activities: ‘If you are not a main contractor for the Global Fund grant, 
your role is limited to implementation of project activities - and that’s it!’ (Georgian CSO).    
 
Have Global Fund HIV/AIDS programmes affected relationships between civil society and 
government?  
An important effect of the Global Fund HIV/AIDS grants has been the increased 
professionalisation of CSOs through both through insisting on CSO grantees adopting 
adequate project management, accounting, grant and financial management and monitoring 
and evaluation practices, and financing for hiring and training managerial and administrative 
staff as well as office equipment (also reported in Kapilashrami and O’Brien 2012). This has 
led to CSOs becoming more respected by government officials in the three countries, has 
helped to build trust, and challenged government stereotypes of CSO organisational capacity. 
In turn this has facilitated CSO engagement with and, ultimately, some influence on 
government HIV/AIDS and drugs policies and programmes and their implementation at local 
level. Moreover, in many cases, being encouraged to work with government officials under 
Global Fund grant activities, such as joint membership of national policy working groups 
and coordinated service delivery between CSO and government HIV services, promoted 
contact between government and CSOs thereby fostering better relationships with 
government, which interviewees saw as enhancing the influence of CSOs on government 
policy. Indeed, adoption of Global Fund procedures by CSOs has had the effect of 
encouraging government institutions to do the same. 
Page 12 of 30
http://mc.manuscriptcentral.com/heapol
Manuscripts submitted to Health Policy and Planning
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 12
 
The introduction of Country Coordination Mechanisms (CCMs) was widely applauded by 
interviewees as a major area in which the Global Fund had enabled CSOs to contribute to 
shaping decisions relating to national HIV/AIDS programmes. Indeed, in each of the three 
countries, the CCM was described by CSO members as a valuable platform for advocating 
on national issues relating to HIV/AIDS including expressing the wishes and needs of 
vulnerable groups including IDUs and CSWs. While this promoted increased interaction 
between civil society and government the fact that CCMs were government dominated in 
terms of numbers of members and control of the agenda meant that CSO voices were in 
practice muted and had limited impact on collective decisions. A government interviewee in 
Kyrgyzstan accepted this reality: ‘The CCM is a country committee under the government...it 
is interpreted as belonging to the government rather than society…based on that, they do not 
want to give many places to the nongovernmental sector’. Furthermore the status of CCMs in 
the three countries as advisory rather than decision-making bodies further attenuated the 
ability of CSOs to advocate on national decisions. In Georgia there was a sense that while 
the CCM was respected by government, when it came to ‘real conflict of interest between 
what the state is interested in and what the CCM might support, then the government’ does 
not take [the CCM] into consideration...’ (Georgian CSO).  
 
Have Global Fund HIV/AIDS programmes affected relationships between civil society 
organisations?   
Interviewees widely accepted that collective action among CSOs strengthened advocacy, 
while CSOs working individually had limited impact on government policy, particularly at 
national level: ‘…one organisation is only one vote. Many voices - that’s the power’ 
(Ukrainian CSO). In all three countries some CSOs were affiliated with networks or 
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coalitions that were reported as strengthening some national level advocacy attempts, 
particularly when common interests and goals were agreed. A Georgian CSO interviewee 
said: ‘It is easier to influence political decisions when the organisation operates in a 
network’. Some CSOs indicated they were members of international networks or were 
closely connected to international CSOs from which they derived resources and power, 
strengthening their voice within their country. Further, knowledge exchange among CSOs 
strengthened advocacy; in some cases it motivated their advocacy efforts: ‘...when we meet 
with others, new ideas come, in my opinion, strengthening is realised when we speak...it 
gives a positive stimulus to keep on working’ (Kyrgyz CSO).  
 
Nevertheless, few interviewees felt the Global Fund had fostered cooperation between CSOs. 
A common observation was that CSOs were fragmented and that competition for scarce 
resources was a key reason for this. Indeed, Global Fund HIV/AIDS grants were reported as 
exaggerating competition among many local CSOs contending for financial resources, a 
problem also reported in Peru where receipt of Global Fund financing fostered competition 
and undermined original affiliations and patterns of CSO collaboration (Caceres et al 2009). 
Interviewees in Kyrgyzstan suggested that Global Fund financing had increased the number 
of CSOs but, in so doing, had effectively spread resources too thinly. For a Kyrgyz CSO 
interviewee, the consequences were clear: ‘Because of Global Fund money, those 
interpersonal relationships between NGOs have worsened: they regularly get into conflict 
with each another’. In Ukraine, a similar experience emerged from the interviews: 
‘…currently, cooperation among organisations is weak because there is incomprehensible 
hidden competition, possibly for funding, possibly for [career advancement]’ (Ukrainian 
CSO). In Georgia, whilst a lack of broad collective action was reported amongst CSOs, who 
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often delivered multiple and sometimes contradictory messages to national government, the 
Global Fund was not identified as a principal or even contributing factor.  
 
Discussion 
The Global Fund and ‘true’ advocacy?  
The aim of our paper is to identify the effects of Global Fund financing on CSO advocacy. 
Financing from external sources inevitably raises the spectre of co-option – how can CSOs 
‘truly’ advocate for the rights of minority groups in society if they enjoy close political ties 
with the very actors that enact policy limiting those rights, or are dependent on others for 
funding? There is insufficient space here to engage fully with a long-standing but ultimately 
unresolved debate about the appropriate role of civil society vis a vis the state (whether 
strong relations between state and civil society are beneficial or inimical to democracy - 
what Foley describes as the ‘paradox of civil society’ (Foley 1996)). Nevertheless, our study 
raises two important points pertinent to this conundrum. First, our results suggest that CSO-
state relations were not so close as to warrant the charge of co-option. Second, we argue that 
co-option is too crude an explanation of the subtle effects of economic dependence we found 
in our study. The extent to which CSOs reconstructed both the meaning of advocacy and 
their own functioning in society in response to the need to win Global Fund grants is a 
striking, if under-reported, example of power-relations between grantor and grantee.  
 
Effects of different components of the Global Fund governance model  
Our study sheds light on what is inevitably a complex relationship between three principal 
actors in IDU policy: the Global Fund, CSOs and governments. If, as many of the 
respondents in our study attest, there is insufficient funding for advocacy, where does 
responsibility lie within the Global Fund to increase its support? Should the CCM be more 
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sensitive to advocacy needs and write them into proposals; should the PRs agree a greater 
allocation of funding for advocacy with the Secretariat in the grant agreement; should the 
Board instigate an advocacy ‘window’ in much the same way as it did for health systems 
strengthening, and encourage CCMs to incorporate specific advocacy activities into grant 
proposals?  
 
The results of our research add a degree of nuance that helps to address this question. It is 
clear that the category of PR is important: whether or not a PR is a CSO or government agent 
appears to affect the level of priority afforded advocacy activities. In countries such as 
Kyrgyzstan and Georgia, where the PRs are government agencies, international donors such 
as OSI, UNAIDS and USAID are in a position – through the technical assistance they 
provide in proposal writing – to encourage the PRs to be more supportive of advocacy 
capacity building. However, this assumes that donors have a common stance towards the 
rights of IDUs and reflect that position consistently. It is by no means clear that this is the 
case.  
 
Nevertheless, the general perception amongst our respondents was that Global Fund-
supported HIV/AIDS programmes attached limited value to civil society advocacy, with 
CSO sub-grantees constructed primarily as service providers. Whether responsibility for the 
low priority attached to advocacy lies at the door of an unresponsive CCM is difficult to 
gauge: on the one hand, interviewees regarded the CCM as an important platform for 
advocacy; on the other, many respondents still regarded the CCM as a government-
controlled institution, and thus inimical to CSO advocacy efforts. A close examination of 
CCM proposals, comparing advocacy components within proposals accepted and rejected, 
may usefully quantify CCM interest in advocacy.   
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Financial incentives reconstruct CSO identity 
Others have identified clear financial incentives for maintaining a prohibitionist stance 
towards drug use leading to widespread police extortion and intimidation of IDUs and CSWs 
(Lewis 2010; SWAN 2009; Kupatadze 2009; Sarang et al 2010). Our study confirms these 
findings and suggests this is also a major factor undermining CSO attempts to change policy 
on drug use. Less well understood are the effects that financial dependence on external 
funding has had on CSO performance. The effects that we identify are not co-optive, in the 
sense that PRs sought to exert political control over sub-recipients of Global Fund grants 
(Rau 2006). Rather, they are reconstructive in the sense that CSOs, under pressure from 
competing CSOs, reconstructed their identities to appear more professional, corporate and 
business-focused organisations in an effort to attract grants.  
 
Advocacy as an event or a process?  
What also emerges from our data is that advocacy strengthening is perceived by the Global 
Fund to be an event rather than a process. Interviewees assert that advocacy is systematic 
work and yet the Global Funded-HIV/AIDS programmes appear to approach advocacy as a 
short-term, one-off training exercise rather than long-term support for CSOs. Part of this 
effect is that increased funding from Global Fund grants is changing the meaning that CSOs 
attach to advocacy. Where once advocacy had ‘value’, now the activity is regarded by some 
CSOs as ‘just another project’ that brings in money. Thus, while the aim of advocacy was to 
reform legislation, the motivation was often grant-focused rather than rights-based. 
Advocacy was seen as instrumental in order to fulfill CSO sub-grantees’ obligations under 
the grant rather than necessarily supporting vulnerable groups by defending their rights. 
Caution is required in attributing responsibility for this shift in priorities to Global Fund 
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grants, as it may reflect a broader dissonance in country wide (that is, government) 
understanding of advocacy and its importance for health systems strengthening.  
 
Have Global Fund programmes fostered an ‘enabling environment’ for CSO advocacy? 
In common with previous studies (Nathan et. al. 2002, Court et. al. 2006, Pollard and Court 
2005), we found that weak capacity of CSOs undermined their ability to influence 
government policy. With the exception of a few high-profile CSOs, the vast majority of 
CSOs in the field of HIV/AIDS in our focus countries are relatively small-scale 
organisations whose advocacy needs are relatively inexpensive. A small amount of financial 
support to strengthen CSO advocacy resources, evidence-gathering, knowledge (particularly 
legal), and skills and leadership development, may help CSOs to advocate with local 
officials to enable them to deliver services to vulnerable groups. The Global Fund is 
beginning to recognise the importance of CSO capacity building. The Round 10 proposal 
form, for example, now includes this as a specific – and major – service delivery area, 
allowing countries to secure funding for specific advocacy training activities.  
 
But we also found that an indirect effect of capacity building from Global Fund grants has 
been to build an ‘enabling environment’ in which communities can advocate for reform of 
government HIV/AIDS-related policies. Our study provides examples of strengthened 
relations between CSOs and government officials that are beginning to erode stereotypes 
each sector has of the other. Increased professionalism among CSOs increased the regard 
many government officials had for them. Indeed, CSO grantees adopting Global Fund 
procedures financial management, administration, and monitoring and evaluation had 
encouraged government institutions to do the same.  
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CSOs competing for Global Fund grants 
Another important consequence of CSO dependence on Global Fund grants in our three 
focus countries is the effect of CSOs competing as sub-recipients for funding. Despite the 
emergence of CSO networks and coalitions, broad collective action has been difficult to 
achieve. Indeed, this finding compares with other regions, such as South America, where on 
one hand HIV/AIDS galvanised a broad based civil society social movement that 
successfully lobbied for legal reform around HIV/AIDS in Brazil which did not have a 
Global Fund programme, while in Peru receipt of Global Fund financing undermined 
affiliations and collaborations among CSOs (Caceres et al 2009; Parker 2009; Kendall and 
Lopez-Uribe 2010). A comprehensive regional comparison of CSO experiences of Global 
Fund support is beyond the scope of this study, but warrants further exploration. 
 
Study limitations 
Our study has a number of limitations. Ongoing political and economic upheaval 
experienced in the three countries means it is difficult to generalise our findings across 
Eastern Europe and Central Asia and beyond. Additionally, sampling was restricted to the 
capitals, which created a selection bias although in Georgia this was less problematic than 
Ukraine and Kyrgyzstan since we interviewed representatives of Georgian 14/16 CSOs 
receiving Global Fund HIV/AIDS grants. The majority of interviewees represented CSOs, 
and while we interviewed key government informants in the field it was difficult to interview 
greater numbers due to problems of availability and in some cases lack of williningness to 
participate. 
 
Conclusion 
Despite concerted efforts by the international community to raise the profile of civil society 
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engagement in the health policy process, the Global Fund’s financing of CSO advocacy – an 
important way that CSOs might be supported to engage in this process – has been limited. 
Partly, this is because relatively limited funding is being channeled directly towards 
advocacy through country HIV/AIDS grants, which emphasise service delivery to achieve 
targets rather than capacity building for advocacy. Obviously, given the Global Fund’s 
principle of country ownership, it is not in a position to positively discriminate against grants 
with an explicit advocacy component.  Nor should it. However, if the Global Fund is serious 
about strengthening communities – as a way to strengthen health systems – it could 
positively promote advocacy as an integral component of health systems strengthening in the 
literature it commissions on CSS and in its R11 guidance notes for grantees. 
 
It is clear that the source of grant proposals, the CCM, is not working as well as it might to 
raise the profile of advocacy. Here too there may be little the Global Fund can do, although it 
does issue guidelines about CSO participation in decision-making within the CCM. Evidence 
from our study suggests that CSO representation on CCMs is often little more than a ‘box-
ticking’ exercise by a government-dominated Board. Currently, additional tranches of 
funding from the Global Fund are tied to grant performance. A way forward may be to 
extend crtieria for ‘performance’ to include broad-based inclusion of stakeholders in CCM 
decision-making.  
 
Funding is mostly short-term, making it impossible for CSOs to establish long-term 
strategies. Short-term funding has also meant short-term training. Whilst it may be unfair to 
describe the advocacy training provided as “jabber about nothing”, it would appear to be of 
variable quality. The responsibility of the Global Fund’s Local Fund Agent (LFA) is to make 
sure that money granted for advocacy is used effectively. It is important therefore for LFAs 
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to be required by the Secretariat to monitor the performance of monies allocated to advocacy 
activities. The Global Fund Secretariat should also reflect on and seek to mitigate the 
negative effects of hierarchy and competition for its funding amongst CSOs. Whilst 
advocacy may now be a higher priority for the Global Fund Secretariat, there is a sense 
among CSOs that this has not yet permeated fully to the Fund’s country level governance 
mechanisms.  
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Table 1 Georgia, Ukraine and Kyrgyzstan: selected data on HIV/AIDS epidemic and Global Fund HIV/AIDS programmes   
 
  
Georgia 
 
Ukraine 
 
Kyrgyzstan 
 
   
Populatione  4M (2009) 46M (2009) 5M (2009)  
Gross national income 
per capitae  
$2,530 $2,800 $870 
Epidemic type  
 
Low-level    Concentrated  Concentrated 
Number of people 
living with HIV/AIDSa  
• 1,136 (2010)  (registered) 
• 3,300 (2009)  (estimated number) 
188,766 (April 2011) 3,288 (January 2011) 
Percentage of adult 
population living with 
HIV/AIDSb  
0.03% (2010) 1.11% (2009) 0.13% (2007) 
HIV prevalence among 
key MARPsfgh 
• IDUs upto 4.5% (2009) 
• CSWs upto 1.8% (2009) 
• MSM upto 3.7% (2009)  
• IDUs 22.9% (2008-9) 
• CSWs 13.2% (2008-9) 
• MSM 8.6% (2009) 
• IDUs 14.3% (2009) 
• CSWs 1.6% (2009) 
• MSM 3.8% (2007)  
 
Global Fund 
HIV/AIDS grantsc  
 
• Round Two (2003-2009) $14,363,254 
• Round Six (2007-2010) $8,533,048 
 
• Round One (2004) $23M 
• Round Six (2007) $131.5M 
 
• Round Two (2003) $17M 
• Round Seven (2008) $11M 
Principal Recipients  The Georgia Health and Social Projects 
Implementation Center (NB: in January 2011 
a nongovernmental organization became PR) 
• International HIV/AIDS Alliance 
(Rounds One and Six)  
• Network of People Living with 
HIV/AIDS (Round Six)  
Republican AIDS Centre (transferred 
to UNDP from July 2011) 
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Global Fund 
HIV/AIDS grants as % 
of total HIV/AIDS 
fundingc  
 
55.3% (2008-9) 
 
72.2% (2004-8) 
 
47% (2007) 
 
Numbers of civil 
society organisations 
funded by Global Fund 
HIV/AIDS grantsd  
 
16 (2010)  
 
156 (2010) 
 
42 (2010) 
Amount of money 
allocated for advocacy 
by Global Fund  
 
Advocacy as % of total 
grantd 
 
• $195,000 (Round 2, 2005) 
• $312,000 (Single Stream Funding, 2006)  
 
 
• 1.4% (Round 2, 2005) 
• 3.7% (Single Stream Funding, 2006) 
• $464,000 (Round 1) 
• $166,000 (Round 6)  
 
 
• 2.0% (Round 1) 
• 0.1% (Round 6)  
 
716,580 (Phase 1 Round 7) 
 
 
 
6.5% (Phase 1 Round 7) 
Sources: (a) Georgia National Centre for Disease Control and Public Health; Ukraine Principal Recipient; Kyrgyzstan National AIDS Report, January 2011; (b) 
Global Fund grant portfolio index: http://portfolio.theglobalfund.org/en/Home/Index; (c) Global Fund grant data: 
http://portfolio.theglobalfund.org/en/Route/DataDownloads; (d) Georgia National Centre for Disease Control and Public Health; Global Fund PIU, Kyrgyzstan; 
Ukraine Principal Recipient (e) World Bank World Development Report 2011 (f) UNGASS Kyrgyzstan Country Progress Report 2010 (g) UNGASS Georgia 
Country Progress Report 2010 (h) UNGASS Ukraine Country Progress Report 2010   
 
 
 
 
 
Page 27 of 30
http://mc.manuscriptcentral.com/heapol
Manuscripts submitted to Health Policy and Planning
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Table 2 CSOs sample description  
 Georgia Kyrgyzstan 
 
Ukraine 
Harm reduction including needle/syringe exchange 
and addiction therapy 
•  •  •  
Education/awareness building    •  •  •  
Condom distribution  •  •  •  
Prevention of mother to child transmission (PMTCT) •    
Voluntary counseling and testing (VCT)  •   •  
Rehabilitation of former prisoners  •   
Detoxification   •   
Care/support   •  •  
Legal support    •   
STI testing   •  
IDUs •  •  •  
PLWHA  •  •  •  
Women •    
Pregnant women •    
Men having sex with men (MSM)  •   •  
CSWs •  •  •  
Children, young people •   •  
Prisoners/former prisoners   •  •  
Women IDUs    •   
General public   •  
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Box 1 CSO advocacy efforts in Georgia, Kyrgyzstan and Ukraine 
 
 
Examples of issues for which CSOs have advocated  
 
• Reduced price antiretroviral drug procurement by the state  
• Drug users and sex workers’ rights including entitlements and exposing corruption and discrimination  
• Introduction of new commodities and approaches such as Methadone opiate substitution therapy (OST), needle/syringe exchange, pre- and 
post-counselling and express testing 
• Decriminalisation of injecting drug use and/or reductions in penalties 
• Adoption of new regulations/protocols for prevention, testing and treatment   
• Advocacy with local law enforcement and health officials to accept CSO harm reduction services and for changes in militia training 
curricula 
• Advocating with local government for the allocation of additional resources  
• Advocating for individual clients’ entitlements  
 
Examples of successful CSO advocacy  
 
• Ukrainian CSOs successfully advocated for the national HIV program to incorporate OST and needle/syringe exchange interventions; for a 
reduction in the price of antiretroviral drugs procured by government; and actively contributed to drafting Global Fund proposals 
• Kyrgyz CSO advocacy precipitated the integration of CSO HIV services within government primary healthcare and the inclusion of social 
aspects of HIV in medical school curricula; also changes in the law on quantities of illicit drugs a person can carry; and to changes in militia 
training curricula 
• Georgian CSO advocacy led to changes in drugs testing protocols in line with the EU Convention of Human Rights 
Source: Spicer et al (2011) 
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Box 2 Global Fund HIV/AIDS grant support for civil society advocacy   
 
 
Georgia  
 
• Supporting the drafting of a proposal document for drugs policy reform developed jointly by government agencies and select CSOs  
• Financing conferences and meetings on harm reduction and other aspects of HIV/AIDS prevention  
 
Ukraine  
 
• Co-financing annual advocacy ‘summer schools’ and other training for civil society Global Fund grantees   
• Principal Recipients providing direct technical assistance to sub-grantees on aspects of advocacy  
• Providing Issuing competitive tenders for specific advocacy activities under the ‘Supportive Environment’ component of the Round Six 
HIV/AIDS grant  
• Developing and distributing advocacy ‘toolkits’ to guide CSO grantees  
• Funding Regional Coordinator posts for which part of the role includes contributing to local level advocacy in support of CSO grantees  
• Financially supporting events including conferences, press conferences, workshops and interagency meetings  
 
Kyrgyzstan  
 
• Financially supporting ‘round table’ interagency meetings on harm reduction and other aspects of HIV/AIDS prevention  
• Providing financial support for organizing Annual NGO Forum, where NGO representatives from different part of the country could 
jointly discuss advocacy issues    
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